España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Vanda Pharma
VNDA
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$4.78
0.15
3.24%
At close: -
$4.78
0.00
0.00%
After Hours: Dec 20, 4:58 PM EDT
Get Report
Comment
Vanda Pharma (VNDA) Forecast
News
Earnings
Vanda Pharma (VNDA) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Vanda Pharma (NASDAQ:VNDA) Stock
Vanda Pharma Stock (NASDAQ: VNDA)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, November 06, 2024
Vanda Pharma Q3 2024 GAAP EPS $(0.09) Beats $...
Benzinga Newsdesk
Vanda Pharma Raises FY2024 Sales Guidance fro...
Benzinga Newsdesk
Friday, November 01, 2024
Over 200% Stock Upside - Vanda Pharmaceuticals Undervalued With Robust Portfolio And Pipeline: Analyst
Vandana Singh
Thursday, October 31, 2024
HC Wainwright & Co. Initiates Coverage On Van...
Benzinga Newsdesk
Monday, October 14, 2024
Vanda Pharmaceuticals Confirms Receipt Of Uns...
Benzinga Newsdesk
Vanda Pharmaceuticals shares are trading high...
Benzinga Newsdesk
Cycle Pharmaceuticals Reaffirms Proposal To A...
Benzinga Newsdesk
Friday, September 20, 2024
VNDA Stock Down as FDA Rejects NDA for Tradipitant in Gastroparesis
Zacks
Thursday, September 19, 2024
Evoke Pharma Reaffirms Its Commitment To Impr...
Benzinga Newsdesk
FDA Strikes Off Vanda Pharmaceuticals' Tradipitant For Stomach Paralysis, Asks For Additional Studies
Vandana Singh
The FDA Declined To Approve Vanda's New Drug ...
Benzinga Newsdesk
Thursday, August 01, 2024
Cantor Fitzgerald Maintains Overweight on Van...
Benzinga Newsdesk
Wednesday, July 31, 2024
Vanda Pharmaceuticals Reinstates Guidance; Se...
Benzinga Newsdesk
Vanda Pharma Q2 2024 GAAP EPS $(0.08) Beats $...
Benzinga Newsdesk
Thursday, July 11, 2024
Cantor Fitzgerald Initiates Coverage On Vanda...
Benzinga Newsdesk
Monday, July 01, 2024
US District Court For The District Of Delawar...
Benzinga Newsdesk
Thursday, June 27, 2024
What's Going On With Vanda Pharmaceuticals Shares Today?
Nabaparna Bhattacharya
Vanda Pharmaceuticals Inc. shares are trading...
Benzinga Newsdesk
Future Pak Late Wednesday Announced The Withd...
Benzinga Newsdesk
Thursday, June 20, 2024
Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
Why Vuzix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Vanda Pharmaceuticals shares are trading lowe...
Benzinga Newsdesk
Vanda Pharmaceuticals And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Avi Kapoor
Reported Wednesday, Vanda Pharmaceuticals Rej...
Benzinga Newsdesk
Thursday, June 13, 2024
Tesla, Nvidia, John Wiley & Sons And Other Big Stocks Moving Higher On Thursday
Avi Kapoor
Vanda Pharmaceuticals Receives Revised Unsoli...
Benzinga Newsdesk
Vanda Pharmaceuticals shares are trading high...
Benzinga Newsdesk
Future Pak Increases Cash Portion Of Its Offe...
Benzinga Newsdesk
Thursday, June 06, 2024
S&P 500 Edges Lower; J. M. Smucker Shares Surge Following Earnings Beat
Avi Kapoor
Why G-III Apparel Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
Crude Oil Jumps 2%; Lululemon Posts Upbeat Earnings
Avi Kapoor
Vanda Pharmaceuticals Receives Another Takeover Proposal, Considers $466M Deal
Vandana Singh
Vanda Pharmaceuticals Confirms Unsolicited, N...
Benzinga Newsdesk
Vanda Pharmaceuticals shares are trading high...
Benzinga Newsdesk
CORRECTION: Vanda Pharmaceuticals shares are ...
Benzinga Newsdesk
Cycle Pharmaceuticals Made A Proposal To Vand...
Benzinga Newsdesk
Thursday, May 30, 2024
Vanda Pharmaceuticals Gains Ownership Of The ...
Benzinga Newsdesk
Friday, May 24, 2024
Vanda Pharmaceuticals Rejects Revised Unsolic...
Benzinga Newsdesk
Wednesday, May 15, 2024
Vanda Pharmaceuticals Announces Positive Resu...
Benzinga Newsdesk
Thursday, May 09, 2024
Exact Sciences Reports Q1 Loss, Joins Beyond Meat, Duolingo And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Avi Kapoor
Wednesday, May 08, 2024
Vanda Pharma Q1 2024 GAAP EPS $(0.07) Misses ...
Benzinga Newsdesk
Tuesday, May 07, 2024
Vanda Pharmaceuticals Confirms Receipt Of Rev...
Benzinga Newsdesk
Vanda Pharmaceuticals shares are trading high...
Benzinga Newsdesk
Future Pak Increases Bid For Vanda Pharmaceut...
Benzinga Newsdesk
Thursday, April 25, 2024
Vanda Pharmaceuticals Shareholder ShareCap Sa...
Benzinga Newsdesk
Monday, April 22, 2024
US Supreme Court Declines To Hear Vanda Pharmaceuticals' Case Regarding Invalidation Of Patents For Its Sleep Disorder Drug, Hetlioz
Vandana Singh
Vanda Pharmaceuticals shares are trading lowe...
Benzinga Newsdesk
'The U.S Supreme Court Has Reportedly Decline...
Benzinga Newsdesk
Friday, April 19, 2024
Butler Hall Capital Has Issued An Open Letter...
Benzinga Newsdesk
Wednesday, April 17, 2024
Crude Oil Dips 3%; U.S. Bancorp Profit Tops Views
Avi Kapoor
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch